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Abstract: The proposed in vivo formation of G-quadruplex
DNA (G4 DNA) in promoter regions of oncogenes and in te-
lomeres has prompted the development of small molecules
with high affinity and selectivity for these structures. Herein
we report the synthesis of a new di-substituted bipyridine
ligand and the corresponding complexes with Ni2 + and
VO2+ . Both these new complexes have been characterized
spectroscopically and by X-ray crystallography. Detailed DNA
binding studies of these two complexes, together with three
previously reported metal salphen complexes, are presented.
Using FRET melting assays, the binding affinity and selectivi-
ty of the five metal complexes against six different G4 DNA
structures as well as a duplex DNA have been determined.
In addition, we present detailed ITC and UV/Vis studies to
characterize the interaction of the complexes with human
telomeric G4 DNA. Finally, we show via a polymerase stop
assay that these complexes are able to stabilize a G4 DNA
structure (from the c-Myc oncogene promoter) and halt the
activity of Taq polymerase.
Introduction
Besides its canonical double-stranded helix, DNA can fold into a
range of different structures such as hairpins, triplexes, cruciform
junctions, i-motifs and G-quadruplexes (G4).[1] The latter forms
from stacks of two or more guanine tetrads that in turn arise
from hydrogen bonding network of four guanines (see Figure 1).
A large number of putative G-quadruplex forming sequences
(ca. 700,000) have been identified in vitro in the human
genome[2] and there is increasing evidence they are involved in
essential biological processes.[3, 4] G-quadruplex-forming sequen-
ces in the human genome are found in telomeres[5] and promot-
er regions of various oncogenes.[6] Consequently, these G4 struc-
tures have been proposed as potential targets for therapeutic in-
tervention and therefore significant research has been carried
out to develop small molecules with high affinity for G4 DNA.[7–9]
One of the biggest challenges when developing small mole-
cules as quadruplex binders is to make them selective for a
given G4 structure over others as well as over duplex DNA.
While all G4 structures share some structural features—for ex-
ample, the stacks of guanine tetrads stabilized by K+ ions—
they show wide structural diversity caused by the strand orien-
tation, base composition, nature of pentose ring, conformation
of glycosidic bonds of guanine bases in the G-quartets, length
and sequence composition of loops/grooves formed.[10, 11]
Initially, most G-quadruplex binding molecules were based
on organic heteroaromatic compounds.[12, 13] Subsequently, it
Figure 1. (a) Schematic representation of a G4 DNA structure highlighting
the guanine tetrad. (b) Chemical structures of metal-salphen (1–3) and
metal-bipyridine (4, 5) complexes studied in this work.
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was shown that metal complexes can also be excellent G4
DNA binders thanks to their unique electronic and structural
features, as has been discussed in detail elsewhere.[14, 15] An ex-
ample of this, are metal salphen and salen complexes, which
have been extensively studied over the past 10 years (see
Figure 1).[16, 17] A wide range of derivatives with different metals
(and hence geometries),[18–20] salphen/salen core structure[21, 22]
and nature/number/position of substituents[19, 23–27] have been
reported as excellent G4 DNA binders. In spite of this, there is
still little information regarding the selectivity of metal-sal-
phens against several different G4 DNA structures.[26]
With the aim of increasing the aromatic planar surface of
metal salphens and hence their G4 DNA binding affinity, herein
we report the synthesis and structural characterisation of two
new metal complexes where Ni2 + (4) and [VO]+ (5) are coordi-
nated to a new 6,6’-diphenyl-2,2’-bipyridine ligand (Figure 1).
The affinities of these complexes (and of the previously report-
ed metal-salphens 1–3) towards six different G-quadruplex
DNA structures have been determined by fluorescence reso-
nance energy transfer (FRET) melting assays. We have also es-
tablished by detailed isothermal titration calorimetry (ITC) and
UV/Vis spectroscopic studies, the affinities and thermodynamic
binding parameters for these complexes towards human telo-
meric G-quadruplex DNA. Finally, using polymerase stop assay
(PSA), we report on the ability of these complexes to stabilise
the G-quadruplex structure in the promoter region of c-Myc
and in doing so halt the activity of a polymerase.
Results and Discussion
Design and synthesis of metal complexes
We previously reported the structural characterization of a
nickel(II) and a copper(II)-salphen complexes bound to human
telomeric G-quadruplex DNA.[17] These structures confirmed
that the square planar metal complexes bind to the external
G-tetrads via p–p stacking interactions. From these structures,
we hypothesized that a system based on a di-substituted bi-
pyridine with four aromatic rings (Figure 1) would have similar
dimensions to the salphen ligand but possess an extra phenyl
ring which could increase the ability of the resulting metal
complexes to interact with the G-tetrad. Besides the polyaro-
matic tetradentate core of the ligand, we designed the system
with two ethyl piperidine substituents analogous to those
present in the successful metal-salphen complexes we have
previously developed.[16, 18] The presence of such substituents is
particularly important to increase the compounds’ water solu-
bility as well as the affinity towards DNA thanks to the positive
charge on the piperidine groups, which are protonated at
physiological pH.
Complexes 1–3 were synthesized as we previously report-
ed[18] while the new complexes 4 and 5 were prepared as
shown in Scheme 1. Several complexes with 6,6’-diphenyl-2,2’-
bipyridine ligand derivatives have been reported.[28, 29] We
therefore adapted some of the previous protocols to prepare
our new ligand (7) and corresponding metal complexes (4 and
5). A Suzuki cross-coupling reaction using 6,6’-dibromo-2,2’-bi-
pyridine and 2,4-dimethoxyphenyl boronic acid was carried
out, followed by demethylation with boron tribromide to yield
compound 7. The phenolic scaffold was metalated by using
Ni2+ or VO2 + salts to yield the corresponding metal-bipyridine
precursor complexes 8 and 9, which were then reacted with
chloroethyl piperidine to yield the new complexes 4 and 5. It
should be pointed out that no vanadyl complexes with 6,6’-di-
phenyl-2,2’-bipyridine ligands have been previously reported.
All compounds were fully characterized by 1H NMR spectrosco-
py (except for the vanadyl complexes 5 and 9 which are para-
magnetic), mass spectrometry and their purity confirmed by el-
emental analyses (see Experimental Details). As described in
the following section, the X-ray crystal structures of com-
Scheme 1. Synthetic route of bipyridine metal complexes studied in this work.
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pounds 4 and 5 were also determined confirming their pro-
posed square planar and square-based pyramidal geometries.
To investigate the ability of the nickel(II) complex 4 to dis-
play p–p interactions in solution (and hence its potential to do
so with G4 DNA), variable concentration 1H NMR spectroscopic
studies were carried out. As has been previously reported, p–p
stacking interactions results in shielding of protons and hence
in lower 1H NMR chemical shifts in comparison to the non-ag-
gregated species. As can be seen in Figure S12, upon increas-
ing the concentration of the complex all the aromatic signals
shifted upfield consistent with the expected increase in p–p in-
teractions.
Similarly, we carried out a variable temperature 1H NMR
spectroscopic study of complex 4 (at constant concentration
see Figure S13). Upon heating the sample up from 20 to 70 8C,
all the aromatic protons shifted. However, in this case two dif-
ferent trends were observed: the resonances between 7.70
and 8.30 ppm all shifted downfield as the temperature in-
creased which is consistent with a decrease of p–p interactions
at higher temperature. On the other hand, the resonances be-
tween 6.20 and 6.40 ppm (which correspond to the protons
next to the O atoms in the di-phenolic ring) shifted upfield.
The opposite shift of these signals in comparison to the other
aromatic protons reflects a more complex set of intermolecular
interactions for the protons in the phenolic ring. It is likely that
these two protons display stronger hydrogen bonding interac-
tions with the solvent which decrease as the temperature in-
creases and therefore an upfield shift is observed.
Structural characterisation of 4 and 5
Single crystals of both complexes 4 and 5 suitable for X-ray
crystallography were obtained. The four aryl rings in the struc-
ture of 4 adopt a distorted conformation (Figure 2); though
the bipyridyl unit is relatively coplanar (the torsion angle be-
tween rings A and B being only ca. 2.58), rings C and D are no-
ticeably twisted with respect to their adjacent pyridyl rings,
the A–C and B–D torsion angles being around 11.9 and 8.68 re-
spectively. For rings A and C there is also a significant fold
component such that O19 lies ca. 1.00  out of the plane of
ring A. This fold distorts the square planar coordination at the
nickel atom such that O14 lies around 0.22  out of the
(Ni,N1,N7,O29) plane (the atoms of which are coplanar to
better than 0.01 ). Similar distortions from a square planar ge-
ometry have been previously observed for other bipyridine
bis-phenol nickel(II) complexes.[28]
The p-ring systems of adjacent molecules pack across two
independent centres of symmetry to form a loosely-linked ex-
tended stack along the crystallographic a axis direction
(Figure 3). The closest approaches are between ring A in one
molecule and ring B in the “below” counterpart (centroid···-
centroid and mean interplanar separations of ca. 3.90 and
3.44 , rings inclined by around 38, interaction a in Figure 3),
between ring B in one molecule and ring C in the “below”
counterpart (centroid···centroid and mean interplanar separa-
tions of ca. 4.00 and 3.33 , rings inclined by ca. 218, interac-
tion b in Figure 5), and between ring B in one molecule and
ring D in the “above” counterpart (centroid···centroid and
mean interplanar separations of around 4.05 and 3.49 , rings
inclined by around 98, interaction c in Figure 3).
The four aryl rings in the structure of 5 (Figure 4) adopt a
similar distorted conformation to that seen in the related
nickel species 4. The bipyridyl unit is again relatively coplanar
with an A–B torsion angle of around 3.08, and rings C and D
are twisted with respect to their adjacent pyridyl rings by ap-
proximately 12.38 and 8.38 respectively. For rings A and C
there is again a significant fold component such that O19 here
Figure 2. The crystal structure of 4. Selected bond lengths () and angles
(8) ; NiN1 1.877(2), NiN7 1.876(2), NiO14 1.8317(18), NiO29 1.8348(17),
N1-Ni-N7 86.75(9), N1-Ni-O14 94.25(8), N1-Ni-O29 178.16(9), N7-Ni-O14
173.46(9), N7-Ni-O29 94.96(8), O14-Ni-O29 84.12(7).
Figure 3. Part of one of the loosely p–p linked stacks of molecules along the
a axis direction present in the crystal of 4. Interactions a, b, and c have cen-
troid···centroid and mean interplanar separations () of ca. a) 3.90 and 3.44,
b) 4.00 and 3.33, and c) 4.05 and 3.49, the ring pairs being inclined by ca. 3,
21 and 98 respectively.
Figure 4. The crystal structure of 5. Selected bond lengths () and angles
(8) ; V1O1 1.6012(11), V1N1 2.0730(12), V1N7 2.0775(12), V1O14
1.9095(10), V1O29 1.9001(11), O1-V1-N1 103.58(5), O1-V1-N7 105.00(5), O1-
V1-O14 112.72(5), O1-V1-O29 110.32(6), N1-V1-N7 79.75(5), N1-V1-O14
86.12(5), N1-V1-O29 145.74(5), N7-V1-O14 141.87(5), N7-V1-O29 86.83(5),
O14-V1-O29 85.33(4).
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lies approximately 0.84  out of the plane of ring A. Unlike the
case with 3, however, where this fold affects the square planar
coordination to the nickel atom, here the square-based pyra-
midal coordination geometry of the vanadium centre is unaf-
fected; the four basal atoms are coplanar to within 0.03  with
the metal lying around 0.61  out of the basal plane in the di-
rection of the apical atom O1.
The p ring systems of adjacent molecules pack across three
independent centres of symmetry to form a sheet of molecules
in the crystallographic ab plane. Figure S4 in the Supporting
Information gives a detailed view of the six p–p interactions
around one molecule, whilst Figure 5 here shows part of one
of the resulting sheets. The closest approaches are between
ring A in one molecule and ring B in a Ci-related counterpart
(centroid···centroid and mean interplanar separations of ca.
3.61 and 3.32 , rings inclined by ca. 48, interaction a in
Figure 5), between ring A in one molecule and ring C across
an independent centre of symmetry (centroid···centroid and
mean interplanar separations of ca. 3.83 and 3.43 , rings in-
clined by ca. 168, interaction b in Figure 5), and between ring
B in one molecule and ring D in the next across another inver-
sion centre (centroid···centroid and mean interplanar separa-
tions of ca. 3.93 and 3.39 , rings inclined by ca. 88, interaction
c in Figure 5).
DNA Affinity: Fluorescence resonance energy transfer (FRET)
melting assays
Previously, we have reported that metal-salphen complexes 1–
3 have high affinity (in particular 1 and 2) towards human telo-
meric G-quadruplex DNA and good selectivity over duplex
DNA,[16, 18] but their binding to a wider range of G-quadruplex
structures and therefore their G4-selectivity has not been pre-
viously studied. Thus, with the aim of comparing the G4 affini-
ty of 1–3 with that of the new complexes 4 and 5 as well as to
establish preferences for a given G4 topology, we carried out
FRET meting assays with a range of G4 DNA and RNA struc-
tures. We studied G-quadruplexes with antiparallel (i.e. 22CTA),
parallel (i.e. 25CEB, c-kit2, c-Myc) as well as mixed/hybrid (i.e.
HTelo21 and Bcl-2) conformations. Structures HTelo21, 25CEB
and 22CTA are derived from telomeric regions while c-Myc, c-
kit2 and Bcl-2 are sequences from oncogene promoter regions.
A duplex DNA (ds26) was also studied to investigate the selec-
tivity for G4 vs. duplex DNA (see Experimental Details for de-
tails of all sequences).
All metal complexes showed higher affinity for G4 over
duplex DNA, with the new complex 4 exhibiting the highest
thermal stabilization effect of all complexes under investigation
(see Figure 6). Amongst the metal-salphens, complex 1 dis-
played the highest stabilization for all G4s confirming our pre-
vious observations for HTelo21 and c-Myc G4 DNA. In the case
of HTelo21, two different transitions in the melting curves were
clearly observed for the square planar metal complexes 1, 2
and 4 (see Figures S18, S19 and S21). This suggests more than
one binding mode for the square planar complexes with the
hybrid HTelo21 structure, which is also consistent with the ITC
data discussed in the next section. With regards to the most
potent stabilizer 4, it showed a moderate affinity towards
duplex DNA suggesting a possible intercalation of the bipyri-
dine moiety between base-pairs of the double-stranded DNA.
Complex 5 showed a similar stabilizing effect on the G-quadru-
plexes than the most potent salphen complex (1) in spite of
having a square based pyramidal geometry. This is likely to be
due to the more extended p-system in the bipyridine bis-
phenol ring as compared to salphen which allows the square-
based pyramidal complex 5 to display a better G4 DNA affinity
than the analogous V-salphen complex 3.
The selectivity of 4 for G4 structures was studied by using a
competition FRET experiment with non-labeled duplex DNA
(ds26). The addition of duplex competitor did not yield any de-
crease in the melting transition up to 25 equiv. of ds26 (i.e.
Figure 5. Part of one of the sheets of p–p linked molecules in the ab plane
present in the crystal of 5. Interactions a, b, and c have centroid···centroid
and mean interplanar separations () of ca. a) 3.61 and 3.32, b) 3.83 and
3.43, and c) 3.93 and 3.39, the ring pairs being inclined by ca. 4, 16 and 88
respectively.
Figure 6. Plot of DTm (radial plot between 0 and 40 8C) of different G-quad-
ruplex DNA structures and one double stranded sequence. Concentration of
oligonucleotides = 0.2 mm ; concentration of complexes (1–5) = 1 mm.
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over 250 equiv. of base pairs) suggesting high selectivity for G-
quadruplexes over duplex DNA as expected from the previous-
ly studied metal-salphen complexes (Figure 7).
DNA binding affinity determined by isothermal titration cal-
orimetry and UV/Vis spectroscopy
The binding affinities (Ka) along with the thermodynamic pa-
rameters of the Gibb’s equation of complexes 1–4 towards
human telomeric G-quadruplex DNA were determined using
isothermal titration calorimetry (ITC) experiments. The binding
isotherms showed one binding event for complex 3, while for
1 and 2 two binding processes were observed (see Figure 8
and S23 in the Supporting Information). Interestingly, com-
plex 4 displayed three independent binding processes
(Figure 10). All the salphen complexes showed binding iso-
therms consistent with exothermic reactions while for the bi-
pyiridine complex 4, the first binding event is governed by an
endothermic process, while the 2nd and 3rd are exothermic (see
Figure 8).
Single site, two-site or three-site binding models[30] were
used to obtain the thermodynamic parameters for the interac-
tion between the complexes and human telomeric G4 DNA
(Table 1). For compounds 1 and 2, the first G4 DNA affinity
Figure 7. A) Melting curves for F-HTelo21-T with increasing concentrations of ds26 in the presence of 1 mm of complex 4. B) Variation of the F-HTelo21-T melt-
ing temperature with increasing concentrations of unlabelled duplex DNA.
Figure 8. ITC titrations of human telomeric G4 DNA (20 mm) with complexes 1 (A) and 4 (B). The concentration of the respective metal complexes was 1 mm.
Table 1. Thermodynamic parameters obtained for the interaction be-
tween the metal complexes and human telomeric G4 DNA by ITC at
298 K.
1 2 3 4
K1  10
15, M1 27060 495 0.90.1 3600900
DH1, kJ mol
1 1353 991 7.10.2 1.20.3
TDS1, kJ mol
1 93.8 60.4 21.1 50
n1 3.70.8 3.170.08 3.330.06 1.00.3
K2  10
–5, M1 5.70.9 1.80.9 – 1100700
DH2, kJ mol
1 893 1612 – 7010
TDS2, kJ mol
1 56.3 131.2 – 23.5
n2 8.50.6 9.30.1 3.80.4
K3  10
–5, M1 – – – 5010
DH3, kJ mol
1 – – – 111
TDS3, kJ mol
1 – – – 12.70.9
n3 8.00.7
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constant (K1) is higher (47 and 27-fold, respectively) than the
second one (K2) (see Table 1) indicating that the first G4 bind-
ing site is less hindered than the second. It could be hypothe-
sized that the two binding events correspond to the com-
pounds binding with different affinity to each of the two exter-
nal G-tetrads in the G4 structure. However, this model is com-
plicated by the observed stoichiometry for the first binding
event (see Table 1) which suggests that ca. 3 to 4 molecules of
the compounds are needed per G4 DNA structure (see below
for further comments on stoichiometry). Both complexes ex-
hibited a higher value of DH than TDS indicating that enthalpy
is the main driver for the interaction between these complexes
and telomeric G4 DNA.
Consistent with the FRET-melting assays and our previous
work,[18] the affinity of 3 for G4 DNA is lower than that of 1
and 2, which can be attributed to the geometries of the com-
plexes: square-based pyramidal for 3 and square planar for 1
and 2. Interestingly, the binding process for 3 is entropically
driven (see Table 1) in contrast to the observations with 1 and
2. This suggests the possibility of a conformational change of
complex 3, the G4 DNA structure or both upon binding. Taking
into account the number of binding processes and the affinity
constants obtained, the affinity of the complexes for telomeric
G4 DNA follow the trend 3 ! 2<1<4 which is consistent with
the FRET melting assays.
There have been relatively few previous reports where ITC
was used to determine the affinities of metal complexes to-
wards G4 DNA.[31–33] One of these studies with metalated por-
phyrin (TMPyP4), found that NiII-TMPyP4 and CuII-TMPyP4 dis-
play high affinities to G4 DNA and four independent binding
sites,[31] which is similar to our observations. In different study,
ITC showed that the binding process (i.e. , enthalpy, entropy
and number of binding sites) between a NiII-bis(phenanthro-
line) complex and telomeric DNA can be affected by the exact
choice of telomeric sequence.[32] With HTelo22 (i.e. the same se-
quence we have used for our studies) it was found that this
NiII complex displayed higher binding affinities than towards
the structurally constrained 26-mer sequence.
As indicated above, for the first binding event of com-
plexes 1–3, ca. 3 to 4 equivalents of the respective compound
per G4 molecule are needed (see Table 1). A similar behavior
has been recently reported for other metal complexes target-
ing G-quadruplex structures.[34, 35] In contrast, complex 4 shows
a one-to-one stoichiometry (n = 1) for the first binding event
although, the subsequent two binding events also show
higher ratios. Interestingly, an analogous three-event model
with n = 1 for the first binding event, has been recently report-
ed for a terpyridine-CuII complex interacting with G4 DNA.[36]
While the number of binding events can be correlated to dif-
ferent sites in the G4 structure (e.g. the two tetrads) it is not
clear why the observed stoichiometries are so high for the
complexes.
We also studied the possibility that different protonation
species could lead to the two-binding process for the interac-
tion of 1 and 2 with HTelo22. Therefore, the basicity of the
complexes was examined by means of UV/Vis spectroscopy at
different pH values. The overlapping of the absorption spectra
showed two distinct isosbestic points at different pH ranges
for 1–4 (see Figure 9 for compound 4), indicating the presence
of three different protonated species (see Figures S24–27 in
Supporting Information). The pKa values were obtained by
plotting the absorbance versus pH and ranged between 7.6–
8.4 (see Supporting Information for all the values) suggesting
that the protonation steps occur in the amino group of piperi-
dine rings in good agreement with values in the literature.[37]
Thus, these values pointed out that the di-protonated species
is the only one present under our experimental conditions and
therefore this species should be involved in both binding
events with telomeric G4 DNA.
Following on from the results described above, the affinities
and binding mode of all metal complexes were studied by
using UV/Vis titration experiments. In agreement with the ITC
studies, the UV/Vis binding isotherms showed one binding
mode for 3 and 5, two for 1 and 2 and three for 4 (see
Figure 10 and Figures S28–S30). It is worth mentioning that
the titrations of metal-salphen complexes were already report-
ed but reaching lower molar ratios (r = [L]/[G4 DNA] and thus,
a second binding process wasn’t previously monitored.
The first binding process of the three salphens complexes
displayed hypochromism. In the case of 1 and 2, this was also
accompanied by a red-shift of the bands which is consistent
with our previous observations, and can be attributed to the
p–p stacking interactions of the metal complexes with the
guanine tetrad. Interestingly, the second binding event for 1
and 2 showed hyperchromism (and no red shift) which is usu-
ally attributed to non-specific interactions such as electrostatic
or van der Waals forces.
Figure 9. Absorbance spectra of 4 recorded with increasing pH (arrow
sense) from 6.0 to 7.8 (A) and from 7.8 to 8.4 (B).
Figure 10. Plots of the UV/Vis titrations of HTelo22 and complexes 1 (A) and
4 (B) ([complex] = 20 mm). Insets are the absorbance binding isotherms
(DAbs/[complex] vs. [HTelo22]/[complex]) of complex 1 at l= 370 nm (A)
and 4 at l = 380 nm (B) with HTelo22.
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Complex 4 showed three binding processes: the first and
third events resulted in hyperchromism in contrast with the
second one that showed hypochromism (Figure S31). More-
over, there is a general red-shift of the spectrum suggesting
the stacking between this nickel(II) complex and the guanine
tetrad. This data is summarized in Table S3.
Due to the different independent DNA binding sites for the
square-planar metal complexes (i.e. 1, 2 and 4), it was not pos-
sible to fit the UV/Vis titration data to a model from which we
could derive the affinity constants for these three complexes.
In the case of the square-based pyramidal V=O complexes 3
and 5, only one binding process was determined by UV/Vis ti-
trations (in agreement with the ITC data previously discussed).
Therefore, it was possible to fit the titration data to a 1:1
model and determine the affinity constants for 3 (logKa = 4.97)
and 5 (logKa = 5.11). The former is consistent with the affinity
determined by ITC (i.e. logK = 4.95, see Table 1)
Polymerase stop assay
To test the ability of the complexes to stabilise G-quadruplexes
in a functional manner, we performed a Polymerase Stop Assay
(PSA) adapted from previously reported protocols.[38, 39] A
60 bases-long template oligonucleotide containing a G4-form-
ing sequence derived from c-Myc promoter was used as a
model for the quadruplex-forming sequences. This was select-
ed since the metal complexes under investigation have an in-
termediate affinity for this sequence as compared to for exam-
ple, HTelo G4 and ds26 DNA. This sequence was mixed with a
short (22 bases long) labelled oligonucleotide with a sequence
complementary to the 3’ overhang of the template. As previ-
ously reported, the ability of a polymerase to elongate the la-
belled-template under different conditions (namely in the pres-
ence/absence of K+ ions or DNA binders) was then studied.
Two control experiments were performed before addition of
the compounds to be tested. In the first of these, no K+ (or
compounds) were added to the mixture which led to the full
elongation of the primer by the polymerase. In contrast, addi-
tion of high concentration of K+ ions to the mixture and
hence formation of G4 DNA in the template sequence led to
the appearance of a new band of intermediate size between
that of the initial (labelled) primer and the fully elongated one.
This indicates that the polymerase is able to extend the primer
but only up to the point where the template forms a G4 DNA
structure that is, roughly a 40-base long oligonucleotide.
Having established this, we then investigated the effect that
increasing amounts of the different compounds had on the
polymerase activity. As can be seen in Figure 11 and Fig-
ure S32–S35, a dose response was observed with the com-
pounds under study. The amount of truncated oligo (i.e. the
40 bases long that stops at the point where the G4 forms on
the template strand) could be quantified by analyzing the in-
tensity of the corresponding band in the gel. This clearly
became more intense as the corresponding G4 binder concen-
tration increased (see Figure 11 for complex 4 as an example).
The intensity of this band was then plotted vs. the concentra-
tion of the compound to obtain EC50 values (see Figure 11 B).
The lowest EC50 value (0.920.03 mm)—that is, the highest
ability to inhibit polymerase mediated by G4 stabilisation—
was obtained for complex 4. This is consistent with the data
discussed in previous sections which showed that this com-
pound has the highest affinity for G4 DNA. On the other hand,
the highest EC50 value (3.80.4 mm), and hence lowest activity,
was obtained for the square-based pyramidal complex 3—
which is again consistent with the affinity of this compound
for G4 DNA as determined by FRET, ITC and UV/Vis studies).
Complexes 1 and 2 displayed EC50 values of 1.30.1 and 1.5
0.2 mm respectively.
Conclusions
The new metal complexes 4 and 5 display high affinity for G4
DNA and selectivity over duplex DNA. As compared to the cor-
responding metal salphen complexes (i.e. 4 cf. 1 and 2 ; and 5
cf. 3), both these complexes are better G4 DNA binders—al-
though in the case of complex 4 a modest affinity to duplex
DNA is also observed. The selectivity of these five complexes
against six different G4 DNA structures of different topology
has been studied via FRET melting assays. All of them show a
preference towards antiparallel and hybrid conformations over
parallel ones.
Figure 11. Polymerase Stop Assay (PSA) with a template strand containing the G4-forming sequence from the c-Myc gene promoter. (A) Image of the poly-
acrylamide gel electrophoresis showing the control lanes (1, 2 and 8) as well as the effect of increasing concentration of compound 4 (0.3, 1, 5, 10 and
20 mm) on the product distribution (lanes 3–7). The band corresponding to the pausing product is indicated with a box. (B) Fitting of the experimental data
obtained from the PSA with metal complexes 1–4.
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To characterise in more detail the interaction between these
complexes and G4 DNA, detailed ITC and UV/Vis studies were
carried out with HTelo DNA as a representative example of a
G-quadruplex structure. The data obtained from these studies
is consistent with the FRET melting assays showing that the
new complex 4 has the highest affinity for G4 HTelo DNA. On
the other hand, as expected, the square-base pyramidal com-
plex 3 has the lowest affinity for G4 DNA. Interestingly, the
analogous vanadyl-bipyridine complex 5 with an extra aromat-
ic ring—has significantly higher affinity for G4 than 3 and of
roughly the same magnitude than the square planar salphen
complexes 1 and 2. This highlights the importance of p–p
stacking in binding to the guanine tetrads. ITC studies have
also showed differences in the detailed binding profile of the
complexes, with distinct number binding events for the square
planar complexes than for the square-based pyramidal ones.
Finally, we show that these complexes have the ability to stop
the Taq polymerase from elongating a primer when a G4 struc-
ture forms in the template strand. The EC50 values determined
by PSA follow the same trend than the affinity of the metal
complexes for G4 DNA.
Experimental Details
Chemicals were purchased from Sigma Aldrich, Alfa Aesar or Acros
Organics and used as received. 1H and 13C NMR spectra were re-
corded by using a 400 or 500 MHz Bruker Avance Ultrashield NMR
spectrometer at 296 K, respectively. Chemical shifts are referenced
to residual deuterated solvent. Mass spectra were obtained by
using electrospray ionisation (ESI) by Mrs. L. Haigh (Imperial Col-
lege London) on a LCT Premier Mass Spectrophotometer. IR spec-
tra were recorded on PerkinElmer Spectrum 100 FT-IR Spectrome-
ter. Compounds microanalysis were performed by Mr. A. Dickerson
(University of Cambridge). Absorption measurements were made
on a PerkinElmer UV/Vis spectrometer. The synthesis of metal-sal-
phen complexes (1–3) was achieved following a previously report-
ed protocol. 6,6’-dibromo-2,2’-bipyridine was prepared by previ-
ously reported procedure.[40]
Synthesis of 6. 6,6’-dibromo-2,2’-bipyridine (0.63 g, 2.0 mmol), 2,4-
dimethoxyphenylboronic acid (0.90 g, 5.0 mmol), 2 m aq. K2CO3
(10 mL) in THF (50 mL) were stirred under N2 atmosphere for
30 min. [Pd(PPh3)4] was then added and the reaction mixture was
left stirring at 70 8C for 48 h. After cooling to room temperature,
the solution was filtered off and activated carbon was added to
the filtrate. The mixture was stirred for further 20 min and then fil-
tered through celite. The solvent was removed under reduced
pressure and the compound was taken up with 2 mL of CHCl3. Ad-
dition of MeOH (30 mL) afforded a white precipitate. The solid was
filtered off and dried under reduced pressure. Yield (0.72 g, 84 %).
1H NMR (400 MHz, CDCl3) d= 8.48 (dd, J = 7.7, 1.0, 1 H, H3), 8.09 (d,
J = 8.6, 1 H, H12), 7.93 (dd, J = 7.9, 1.0, 1 H, H5), 7.83 (t, J = 7.8, 1 H,
H4), 6.72 (dd, J = 8.6, 2.4, 1 H, H11), 6.62 (d, J = 2.4, 1 H, H9), 3.92 ppm
(s, 6 H, H13, 14).
13C NMR (100 MHz, CDCl3) d= 161.3, 158.5, 155.9,
154.6, 136.4, 132.3, 124.5, 122.3, 118.5, 105.3, 98.9, 55.6, 55.5 ppm.
MS (ES+ , CH3Cl) m/z = 429 [M+H
+] . HRMS (ES +) ; found: 429.1817,
elemental analysis calcd (%) for C26H25N2O4 : 429.1814. EA: found: C
72.69, H 5.59, N 6.76, calcd for C26H24N2O4 : C 72.88, H 5.65, N 6.54;
mp. 218–220 8C
Synthesis of 8. Compound 6 (0.11 g, 0.27 mmol) in dry DCM
(15 mL) was stirred under nitrogen at 79 8C for 30 min and BBr3
(0.30 g, 1.2 mmol) was added and stirred overnight at room tem-
perature. The solution was combined with H2O (20 mL) and the or-
ganic phase extracted with CH2Cl2 (3  20 mL). The organic phase
was evaporated, dried under reduced pressure to afford 7 and
used in the following step without further purification. Yield (0.1 g,
98 %). MS (ES+) m/z = 373 [M+] . Crude compound 7 (0.1 g,
0.27 mmol) and Ni(OAc)2·4 H2O (0.07 g, 0.27 mmol) in EtOH (30 mL)
were stirred at 60 8C for 3 h during which time a dark red/brown
precipitate formed. The solution was then cooled down to room
temperature and the precipitate was filtered off, washed with wa-
ter:EtOH (1:1, 3  15 mL) and dried under reduced pressure. Yield
(0.11 g, 92 %). 1H NMR (400 MHz, [D6]DMSO) = 9.64 (s, 2 H), 8.16 (d,
J = 8.0, 2 H), 8.13–8.00 (m, 4 H), 7.78 (d, J = 9.0, 2 H), 6.22 (d, J = 2.4,
2 H), 6.16 (dd, J = 8.9, 2.5, 2 H). MS (ES+) m/z = 429 [M+] .
Synthesis of 9. Compound 6 (0.17 g, 0.41 mmol) in dry CH2Cl2
(20 mL) was stirred under nitrogen at 79 8C for 30 min and BBr3
(0.45 g, 1.8 mmol) was added and stirred overnight at room tem-
perature. The solution was combined with H2O (20 mL) and the or-
ganic phase extracted with CH2Cl2 (3  20 mL). The organic phase
was evaporated, dried under reduced pressure to afford 6 and
used in the following step without further purification. Yield
(0.17 g, 98 %). MS (ES +) m/z = 373 [M +] . Crude compound 6
(0.17 g, 0.46 mmol) and VOSO4·0.5H2O (0.08 g, 0.46 mmol) in MeOH
(50 mL) were stirred at 50 8C for 15 h while a dark green precipitate
formed. The solution was then cooled down to room temperature,
filtered off and the precipitate washed with water (10 mL), MeOH
(10 mL) and EtOH (10 mL) and dried under reduced pressure. Yield
(0.09 g, 44 %). MS (ES+) m/z = 438 [M+H+] . IR (KBr): ñ= 1610 (m),
1555 (m), 1464 (m), 1317 (m), 1180 (m), 1112 (m), 976 (s), 794 cm1
(s).
Synthesis of 4. Compound 8 (0.10 g, 0.23 mmol) and K2CO3
(0.06 g, 0.46 mmol) were stirred in dry DMF (30 mL) under N2 at-
mosphere for 10 min. 1-(2-chloroethyl)piperidine hydrochloride
(0.085 g, 0.46 mmol) was then added and the reaction mixture was
stirred at room temperature for 72 h. The solution was concentrat-
ed under reduced pressure to ca. 2 mL and water added (50 mL).
The red precipitate that formed was filtered off, washed with water
(40 mL) and diethyl ether (20 mL) and dried under reduced pres-
sure to give an orange/red powder. Yield: (0.092 g, 62 %). Crystals
of 4 suitable for X-ray analysis were obtained by slow diffusion of
Et2O into a CH2Cl2 solution of the complex.
1H NMR (400 MHz,
[D6]DMSO) d= 8.24 (d, J = 7.5 Hz, 1 H, H3), 8.16 (d, J = 7.7 Hz, 1 H,
H5), 8.10 (t, J = 7.9 Hz, 1 H, H4), 7.86 (d, J = 9.2 Hz, 1 H, H12), 6.35 (d,
J = 2.6 Hz, 1 H, H9), 6.27 (dd, J = 9.1, 2.6 Hz, 1 H, H11), 4.07 (t, J =
5.9 Hz, 2 H, H13), 2.66 (t, J = 5.9 Hz, 2 H, H14), 2.44 (m, 4 H, H15), 1.52
(m, 5 H, H16), 1.39 ppm (m, 2 H, H17). MS (ES
+ , MeOH, CHCl3) m/z =
651.3 [M+H+] , 673.2 [M+Na+] . EA (%): Found: C 62.55, H 5.95, N
7.97; calcd for C36H40N4O4Ni·HCl: C 62.86, H 6.01, N 8.14. IR (KBr):
ñ= 2939 (w), 1604 (s), 1571 (s), 1536 (m), 1461 (s), 1403 (m), 1234
(m), 1211 (s), 1186 (s), 999 (m) 836 (m), 773 cm1 (m).
Synthesis of 5. Compound 9 (0.10 g, 0.23 mmol), K2CO3 (0.06 g,
0.46 mmol) and 1-(2-chloroethyl)piperidine hydrochloride (0.08 g,
0.46 mmol) in dry DMF (20 mL) were stirred at room temperature
under N2 atmosphere for 48 h. The solution was filtered, the filtrate
concentrated to ca. 2 mL and water added (50 mL). The precipitate
that formed was filtered off, washed with water (30 mL) and dieth-
yl ether (20 mL) and dried under reduced pressure to give a light
green powder. The residue was then dissolved in CH2Cl2 (3 mL)
and the complex was precipitated with n-pentane. Yield: (0.064 g,
43 %). MS (ES+ , CHCl3) m/z = 660.3 [M+H
+] ; EA (%): Found: C
62.26, H 5.98, N 8.04; calcd for C36H40N4O5V·2 H2O: C 62.15, H 6.37,
N 8.05. IR (KBr): ñ= 2927 (w), 1601 (s), 1572 (s) 1544 (m), 1460 (s),
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1397 (m), 1353 (m), 1242 (m), 1179 (s), 1116 (m), 1033 (m), 1001
(m), 983 (s), 839 cm1 (m).
X-Ray Crystallography
Crystal data for 4 : C36H40N4NiO4·3(H2O), M = 705.48, triclinic, P1̄
(no. 2), a = 9.5217(3), b = 11.7214(6), c = 15.7343(5) , a = 93.857(3),
b= 106.015(3), g= 96.053(3)8, V = 1669.97(12) 3, Z = 2, 1cald =
1.403 g cm3, m(CuKa) = 1.299 mm
1, T = 173 K, orange needles,
Oxford Diffraction Xcalibur PX Ultra diffractometer; 6452 independ-
ent measured reflections (Rint = 0.0287), F
2 refinement,[41, 42]
R1(obs) = 0.0486, wR2(all) = 0.1393, 5167 independent observed ab-
sorption-corrected reflections [jFo j >4s(jFo j), 2qmax = 1458] , 457
parameters. CCDC 1005613 contains the supplementary crystallo-
graphic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre.
Crystal data for 5 : C36H40N4O5V, M = 659.66, monoclinic, P21/c
(no. 14), a = 8.80002(8), b = 11.49998(9), c = 31.1294(3) , b=
92.3648(8)8, V = 3147.61(5) 3, Z = 4, 1cald = 1.392 g cm
3, m(CuKa) =
3.047 mm1, T = 173 K, dark orange tabular needles, Oxford Diffrac-
tion Xcalibur PX Ultra diffractometer; 6162 independent measured
reflections (Rint = 0.0233), F
2 refinement,[41, 42] R1(obs) = 0.0335,
wR2(all) = 0.0943, 5763 independent observed absorption-corrected
reflections [jFo j >4s(jFo j), 2qmax = 1458] , 444 parameters. CCDC
1005614.
Oligonucleotides and stock solution preparation. Non-labelled
oligonucleotides and labelled oligonucleotides of double HPLC-
grade purity were purchased from Eurogentec (Belgium). The la-
belled sequences used were 5’-FAM-dGGG(TTAGGG)3-TAMRA-3’ for
telomeric G4 DNA (F-HTelo21-T), 5’-FAM-dTGAGGGTGGG-
TAGGGTGGGTAA-TAMRA-3’ for c-Myc, 5’-FAM-dGGGAGGGCGCTGG-
GAGGAGGG-TAMRA-3’ for c-kit2, 5’-FAM-dAGGGCTAGGGCTAGGGC-
TAGGG-TAMRA-3’ for 22CTA, 5’-FAM- dAAGGGTGGGTG-
TAAGTGTGGGTGGGT-TAMRA-3’ for 25CEB, 5’-FAM-
dGGGCGCGGGAGGAAGGGGGCGGG-TAMRA-3’ for Bcl-2 and 5’-FAM-
CAATCGGATCGAATTCGATCCGATTG-TAMRA-3’ for ds26 (donor fluo-
rophore FAM, 6-carboxyfluorescein; acceptor fluorophore TAMRA,
6-carboxy-tetramethylrhodamine). The unlabelled oligonucleotides
used had the same sequence except for telomeric G4 DNA that 5’-
dAGGG(TTAGGG)3-3’ was used (HTelo22).
Tested compounds were dissolved in DMSO to give 10 mm stock
solutions. All solutions were stored in 100 mL aliquots at 20 8C,
thawed, and diluted immediately before use. Oligonucleotide con-
centrations were calculated using the following extinction coeffi-
cients e (L cm1 mol1) at 260 nm given by the supplier: 228500
(HTelo22), 232000 (c-Myc), 258 900 (ds26), 205 600 (c-kit2), 220 400
(22CTA), 265 100 (25CEB), 231 300 (Bcl-2) and 220 590 (F-HTelo21-T).
Under our experimental conditions the absorbance values were
proportional to the metal complex concentrations, thus excluding
aggregate formation. Extinction coefficients were calculated in Tris
buffer (50 mm) supplemented with 10 mm KCl, pH 7.0, T = 25 8C. e
(L cm1 m1): 23 200 for 1 (l= 370 nm), 22 500 for 2 (l= 380 nm),
23 700 for 3 (l= 322 nm), 18 500 for 4 (l= 290 nm).
Isothermal Titration Calorimetry (ITC). The ITC experiments were
performed at 25 8C with a Nano ITC (TA Instruments, Newcastle,
USA). Solutions were degassed in a degassing station (TA, Waters
LLC, New Castle, USA) to minimize the formation of bubbles
during the titration. In the course of the titration, the compound
was injected (25 injections of 2.02 mL) into the calorimetric cell
(187 mL) containing the HTelo22 (i.e. dGGG(TTAGGG)3A) solution in
50 mm Tris-HCl, 10 mm KCl at pH 7.0. The stirring speed was main-
tained constant at 250 rpm. Control experiments were carried out
to subtract the contribution of the heat of dilution of the com-
plexes. The resulting thermograms (integrated area of the peak/
mole of injectant versus [complex]/[HTelo22] ratio) obtained in the
titrations were treated with model equations for single, two or
three independent modes of binding using the Nano Analyze Soft-
ware (TA Instruments, Newcastle, USA).[30] The thermodynamic pa-
rameters were obtained from two independent experiments.
UV/Vis spectroscopy. Spectrophotometric measurements were
performed with a HP 8453A photodiode array spectrophotometer
(Agilent Technologies, Palo Alto, CA) endowed with a temperature
control Peltier system. Titrations were carried out by adding in-
creasing amounts of HTelo22 solution (between 0 and 2 equiv) to
the complex solution in 1 cm pathlength cells with black quartz
sides (50 mm Tris-HCl, 10 mm KCl, pH 7.0, T = 25 8C). The absorb-
ance data were corrected by the dilution factor. For complexes 3
and 5, the affinity constants were obtained according to the inde-
pendent-site model by nonlinear fitting (see details in the Support-
ing Information).[43] The titrations were performed in triplicate.
FRET melting assays. Doubly labelled and non-labelled oligonucle-
otides (FAM/TAMRA labelling) were prepared as 20 mm stock solu-
tions in MilliQ water and stock solutions of 0.4 mm were annealed
in cacodylate buffer (10 mm, pH 7.4) supplemented with potassium
depending on the sequence (c-Myc : 1 mm KCl + 99 mm LiCl ;
HTelo22, 22CTA, c-kit2, ds26, 25CEB: 10 mm KCl + 90 mm LiCl; Bcl-2 :
100 mm KCl). For FRET melting experiments 8-well optical tube
strips were used. The final volume of each sample was 40 mL, with
a final DNA concentration of 0.20 mm and increasing concentration
of tested compound (0–8 mm). Measurements were performed on
a PCR Stratagene Mx3005P (Agilent Technologies) with FAM excita-
tion at 450–495 nm and detection at 515–545 nm. Readings were
taken from 25 8C to 95 8C every 0.5 8C and at 1 8C min1 melting
rate. To obtain melting curves, normalised FAM fluorescence signal
was plotted against temperature. From the non-linear fitting of the
plot DTm [Tm (with ligand)—Tm (without ligand) obtained from at
least three independent measurements] vs. ligand concentration,
the DTm value for 1 mm concentration of ligand was obtained. In
the case of the competition assays, each well was prepared with a
final labelled oligo concentration of 0.20 mm, 1 mm compound, and
increasing concentration of non-labelled oligonucleotide to test
(0.2, 1 and 2 mm).
Polymerase Stop Assay. The oligonucleotide containing a quadru-
plex-forming sequence derived from c-Myc oncogene (5’-
GCGGCTCCTGTGAGGGTGGGGAGGGTGGGGAAGATTCCCGACTTCG-
TATTAAGTACTCTAGCCTT-3’) and the corresponding partially com-
plementary FAM label-sequence (5’-FAM-AAGGCTAGAGTACTTAA-
TACGA-3’) were used. A mixture of each oligonucleotide (1 mm
each) and increasing concentrations of the compounds (0, 0.3, 1, 5,
10 and 20 mm) were annealed in Tris buffer (50 mm, pH 7.4). After
cooling to room temperature, the PSA reactions were performed in
1x Taq buffer, containing the previously annealed solution (0.2 mm),
dNTPs (0.2 mm), MgCl2 (1.25 mm) and Taq DNA polymerase (2.5 U)
at 37 8C during 30 min. The reactions were quenched by adding an
equal volume of stop buffer (90 % formamide, 10 mm NaOH). PSA
products were then analysed on a denaturing polyacrylamide gel
(20 %) in 1x TBE and visualized in FAM dye channel. As a control
experiment, the same protocol was followed using the non-form-
ing quadruplex sequence (5’-GCGGCTCCTGTGAGGGTGAA-
GAGGGTGGGGA AGATTCCCGACTTCGTATTAAGTACTCTAGCCTT-3’) as
a template oligonucleotide.
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Binding Studies of Metal–Salphen and
Metal–Bipyridine Complexes towards
G-Quadruplex DNA
G4 Binders : G-quadruplex DNA is
emerging as a new target for anticancer
agents, which has prompted the devel-
opment of small molecules with high af-
finity and selectivity for these structures.
Herein a detailed study is reported of
the G4 DNA binding properties of five
metal complexes and shows their selec-
tivity profile. It is demonstrated that
these complexes stabilize G4 DNA and
in doing so stop the activity of a poly-
merase.
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